Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLINTHERA.2006.01.010PMID 16490582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative efficacy of oral extended-release hydromorphone and immediate-release hydromorphone in patients with persistent moderate to severe pain: two randomized controlled trials.

  2005cited by this paper
• MorphiDex® (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: Three multicenter, randomized, double‐blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance

  2005cited by this paper
• Ethical principles for medical research involving human subjects.

  2001cited by this paper
• Management of cancer pain.

  2001cited by this paper
• Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.

  2000cited by this paper
• Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

  1999cited by this paper
• The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society.

  1998cited by this paper
• Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.

  1998cited by this paper
• Analgesic Efficacy of Controlled‐Release Oxycodone in Postoperative Pain

  1996cited by this paper
• Opioid therapy for chronic nonmalignant pain: a review of the critical issues.

  1996cited by this paper
• Opioid Analgesics

  1996cited by this paper
• Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain

  1994cited by this paper
• Long-term oral opioid therapy in patients with chronic nonmalignant pain.

  1992cited by this paper
• The Design of Analgesic Clinical Trials

  1991cited by this paper
• Treatment Principles for the Use of Opioids in Pain of Nonmalignant Origin

  1991cited by this paper
• Opioid Analgesia: Recent Advances in Systemic Administration

  1990cited by this paper
• Goodman and Gilman's the Pharmacological Basis of Therapeutics

  1986cited by this paper
• Opioid analgesics in the management of clinical pain

  1986cited by this paper
• The treatment of cancer pain.

  1985cited by this paper
• Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

  1983cited by this paper
• Advances in Pain Research and Therapy

  1980cited by this paper
• CLINICAL MEASUREMENT OF PAIN

  1979cited by this paper
• Relative analgesic potencies of morphine and hydromorphone in postoperative pain.

  1975cited by this paper
• International Encyclopedia of Pharmacology and Therapeutics

  1967cited by this paper

• Inadequate Cancer Pain Control after Switching High-Dose Fentanyl to Hydromorphone Injection: A Case Series Highlighting Issues with Conventional Conversion Ratios

  2025cites this paper
• The 50% effective dose of hydromorphone and morphine for epidural analgesia in the hemorrhoidectomy: a double-blind, sequential dose-finding study

  2024cites this paper
• Opioid Switch Dosing in Chronic Cancer Pain: A Prospective Longitudinal Study

  2023cites this paper
• Opioid Treatments for Chronic Pain

  2020cites this paper
• A double-blind, randomized comparative study to investigate the morphine to hydromorphone conversion ratio in Japanese cancer patients

  2018cites this paper
• Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.

  2017cites this paper
• The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.

  2017cites this paper
• Hydromorphone: evolving to meet the challenges of today's health care environment.

  2013cites this paper
• Interventions for the reduction of prescribed opioid use in chronic non-cancer pain.

  2013cites this paper
• Opioids compared to placebo or other treatments for chronic low-back pain.

  2013cites this paper
• Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review

  2011cites this paper
• Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly

  2010cites this paper
• Dose conversion between tapentadol immediate and extended release for low back pain.

  2010cites this paper
• Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation

  2010cites this paper
• Gastrointestinal symptoms under opioid therapy: A prospective comparison of oral sustained‐release hydromorphone, transdermal fentanyl, and transdermal buprenorphine

  2009cites this paper
• Nursing advocacy and the accuracy of intravenous to oral opioid conversion at discharge in the cancer patient

  2009cites this paper
• An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS® hydromorphone in patients with chronic cancer pain

  2009cites this paper
• Kapitel 32: Grundlagen der medikamentösen Schmerztherapie in der Onkologie

  2009cites this paper
• A new extended release formulation (OROS®) of hydromorphone in the management of pain

  2008cites this paper
• Conversion from Standard Opioid Therapy to Once-daily Oral Extended-release Hydromorphone in Patients with Chronic Cancer Pain

  2008cites this paper
• Less nausea, emesis, and constipation comparing hydromorphone and morphine? A prospective open-labeled investigation on cancer pain

  2008cites this paper
• Opioid Conversions in Acute Care

  2007cites this paper
• Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

  2007cites this paper
• Endogenous opiates and behavior: 2006.

  2007cites this paper
• Methadone for cancer pain.

  2007cites this paper
• Opioid-induced Constipation – Mechanisms , Relevance and Management Constipation

  year unknowncites this paper